Asia-Pacific Rapid Diagnostic Tests (RDT) Market to 2032
Overview
The Asia-Pacific Rapid Diagnostic Tests (RDT) Market is expected to reach a 30.61 USD Billion by 2032 and is projected to grow at a CAGR of 14.51% from 2025 to 2032.
Revenue, 2024 (USD Billion)
14.45
Forecast, 2032 (USD Billion)
30.61
CAGR, 2024 - 2032
14.51%
Report Coverage
Asia-Pacific
Asia-Pacific Rapid Diagnostic Tests (RDT) Market 2018-2032 USD Billion
Asia-Pacific Rapid Diagnostic Tests (RDT) Market, Key Findings (2025-2032)
Market Growth and Projections:
- Market Size (2024): 14.45 USD Billion
- Projected Market Size (2032): 30.61 USD Billion
- CAGR (2025-2032): 14.51%
Key Findings of Asia-Pacific Rapid Diagnostic Tests (RDT) Market
- The Asia-Pacific Rapid Diagnostic Tests (RDT) Market was valued at 14.45 USD Billion in 2024.
- The Asia-Pacific Rapid Diagnostic Tests (RDT) Market is likely to grow at a CAGR of 14.51% during the forecast period of 2024 to 2032.
- In 2024, the Largest segment Adult in Age Group Segment accounted for the largest share of the market with a revenue of 12.40 USD Billion
- The fastest growing segment Determining Confirmation in Test Type Segment grew Fastest with a CAGR of 17.04% during the forecast period from 2024 to 2032.
Asia-Pacific Rapid Diagnostic Tests (RDT) Market Scope
Asia-Pacific Rapid Diagnostic Tests (RDT) Market Segmentation & Scope
Distribution Channel
- Retail Sales
- Direct Tender
End User
- Research And Academic Institutes
- Home Care Setting
- Others
- Diagnostic Laboratory
- Hospital & Clinic
Application
- Others
- Toxicology Testing
- Pregnancy & Fertility Testing
- Drugs-Of-Abuse Testing
- Cardiometabolic Testing
- Oncology Testing
- Cardiology Testing
- Glucose Monitoring
- Infections Disease Testing
Test Type
- Viral Sequencing
- Serological Testing
- Determining Confirmation
Approach
- Molecular Diagnostic
- In-Vitro Diagnostic
Specimen
- Others
- Sputum
- Saliva
- Urine
- Blood
- Swab
Age Group
- Pediatric
- Adult
Product Type
- Others
- Instruments
- Consumables and Kits
Mode
- Over-the-Counter
- Professional
Modality
- Non-Laboratory Based Test
- Laboratory Based Test
Technology
- Others
- Substrate Technology
- Microfluidics
- Agglutination Assay
- Lateral Flow Immunochromatographic Assays
- Flow-Through Assays
- PCR-Based
Asia-Pacific Rapid Diagnostic Tests (RDT) Market Data Coverage Insights
| Study Period | 2024-2032 |
| Base Year | 2020 |
| Unit | Revenue in USD Billion |
| Market Value in 2024 | 14.45 USD Billion |
| Market Value in 2032 | 30.61 USD Billion |
| CAGR (2025-2032) | 14.51% |
| Historic Data | 2016-2023 |
| Market Segments Covered | Distribution Channel, End User, Application, Test Type, Approach, Specimen, Age Group, Product Type, Mode, Modality, Technology |
Regional Insights:
-
Leading Market (2024-2032): Asia-Pacific, leading in terms of revenue 14.45 USD Billion in 2024
- Key Country: China, leading in terms of revenue with value of 4,970.93 USD Million in 2024.
Segments and Scope
-
Asia-Pacific Rapid Diagnostic Tests (RDT) Market to 2032, By Distribution Channel
- Direct Tender is the largest segment in Asia-Pacific Rapid Diagnostic Tests (RDT) Market to 2032 with a revenue of 9.07 USD Billion in the year 2024.
- Direct Tender is the Fastest growing segment in Asia-Pacific Rapid Diagnostic Tests (RDT) Market to 2032 with a Growth rate of 15.40 % in forecast period 2025-2032.
-
Asia-Pacific Rapid Diagnostic Tests (RDT) Market to 2032, By End User
- Hospital & Clinic is the largest segment in Asia-Pacific Rapid Diagnostic Tests (RDT) Market to 2032 with a revenue of 8.13 USD Billion in the year 2024.
- Hospital & Clinic is the Fastest growing segment in Asia-Pacific Rapid Diagnostic Tests (RDT) Market to 2032 with a Growth rate of 15.28 % in forecast period 2025-2032.
-
Asia-Pacific Rapid Diagnostic Tests (RDT) Market to 2032, By Application
- Infections Disease Testing is the largest segment in Asia-Pacific Rapid Diagnostic Tests (RDT) Market to 2032 with a revenue of 5.33 USD Billion in the year 2024.
- Infections Disease Testing is the Fastest growing segment in Asia-Pacific Rapid Diagnostic Tests (RDT) Market to 2032 with a Growth rate of 16.96 % in forecast period 2025-2032.
-
Asia-Pacific Rapid Diagnostic Tests (RDT) Market to 2032, By Test Type
- Determining Confirmation is the largest segment in Asia-Pacific Rapid Diagnostic Tests (RDT) Market to 2032 with a revenue of 6.63 USD Billion in the year 2024.
- Determining Confirmation is the Fastest growing segment in Asia-Pacific Rapid Diagnostic Tests (RDT) Market to 2032 with a Growth rate of 17.04 % in forecast period 2025-2032.
-
Asia-Pacific Rapid Diagnostic Tests (RDT) Market to 2032, By Approach
- In-Vitro Diagnostic is the largest segment in Asia-Pacific Rapid Diagnostic Tests (RDT) Market to 2032 with a revenue of 10.86 USD Billion in the year 2024.
- In-Vitro Diagnostic is the Fastest growing segment in Asia-Pacific Rapid Diagnostic Tests (RDT) Market to 2032 with a Growth rate of 15.00 % in forecast period 2025-2032.
-
Asia-Pacific Rapid Diagnostic Tests (RDT) Market to 2032, By Specimen
- Swab is the largest segment in Asia-Pacific Rapid Diagnostic Tests (RDT) Market to 2032 with a revenue of 6.81 USD Billion in the year 2024.
- Swab is the Fastest growing segment in Asia-Pacific Rapid Diagnostic Tests (RDT) Market to 2032 with a Growth rate of 16.09 % in forecast period 2025-2032.
-
Asia-Pacific Rapid Diagnostic Tests (RDT) Market to 2032, By Age Group
- Adult is the largest segment in Asia-Pacific Rapid Diagnostic Tests (RDT) Market to 2032 with a revenue of 12.40 USD Billion in the year 2024.
- Adult is the Fastest growing segment in Asia-Pacific Rapid Diagnostic Tests (RDT) Market to 2032 with a Growth rate of 14.76 % in forecast period 2025-2032.
-
Asia-Pacific Rapid Diagnostic Tests (RDT) Market to 2032, By Product Type
- Consumables and Kits is the largest segment in Asia-Pacific Rapid Diagnostic Tests (RDT) Market to 2032 with a revenue of 8.45 USD Billion in the year 2024.
- Consumables and Kits is the Fastest growing segment in Asia-Pacific Rapid Diagnostic Tests (RDT) Market to 2032 with a Growth rate of 15.98 % in forecast period 2025-2032.
-
Asia-Pacific Rapid Diagnostic Tests (RDT) Market to 2032, By Mode
- Professional is the largest segment in Asia-Pacific Rapid Diagnostic Tests (RDT) Market to 2032 with a revenue of 11.15 USD Billion in the year 2024.
- Professional is the Fastest growing segment in Asia-Pacific Rapid Diagnostic Tests (RDT) Market to 2032 with a Growth rate of 14.79 % in forecast period 2025-2032.
-
Asia-Pacific Rapid Diagnostic Tests (RDT) Market to 2032, By Modality
- Laboratory Based Test is the largest segment in Asia-Pacific Rapid Diagnostic Tests (RDT) Market to 2032 with a revenue of 10.42 USD Billion in the year 2024.
- Laboratory Based Test is the Fastest growing segment in Asia-Pacific Rapid Diagnostic Tests (RDT) Market to 2032 with a Growth rate of 14.88 % in forecast period 2025-2032.
-
Asia-Pacific Rapid Diagnostic Tests (RDT) Market to 2032, By Technology
- PCR-Based is the largest segment in Asia-Pacific Rapid Diagnostic Tests (RDT) Market to 2032 with a revenue of 6.25 USD Billion in the year 2024.
- PCR-Based is the Fastest growing segment in Asia-Pacific Rapid Diagnostic Tests (RDT) Market to 2032 with a Growth rate of 16.00 % in forecast period 2025-2032.
Asia-Pacific Rapid Diagnostic Tests (RDT) Market Company Share Analysis
| Company Name |
|
||
| PerkinElmer Inc. | |||
| Quidel Corporation | |||
| Bio-Rad Laboratories, Inc. | |||
| Cardinal Health | |||
| Abbott | |||
Asia-Pacific Rapid Diagnostic Tests (RDT) Market Geographical Sales Distribution, 2018-2032 USD Billion
Asia-Pacific Rapid Diagnostic Tests (RDT) Market Company Profiling
Industry Related Reports
Frequently Asked Questions
The Asia-Pacific Rapid Diagnostic Tests (RDT) Market is segmented based on Segmentation Distribution Channel, End User, Application, Test Type, Approach, Specimen, Age Group, Product Type, Mode, Modality, Technology.
Asia-Pacific Rapid Diagnostic Tests (RDT) Market was valued at USD 14.45(Revenue in USD Billion) in 2020.
Asia-Pacific Rapid Diagnostic Tests (RDT) Market is projected to grow at a CAGR of 14.51% during the forecast period of 2024 to 2032.
The Adult segment is expected to dominate the Asia-Pacific Rapid Diagnostic Tests (RDT) Market, holding a largest market share of 12.40 USD Billion in 2024
Coming Soon....
Asia-Pacific Rapid Diagnostic Tests (RDT) Market Scope
Asia-Pacific Rapid Diagnostic Tests (RDT) Market Segmentation & Scope
Distribution Channel
- Retail Sales
- Direct Tender
End User
- Research And Academic Institutes
- Home Care Setting
- Others
- Diagnostic Laboratory
- Hospital & Clinic
Application
- Others
- Toxicology Testing
- Pregnancy & Fertility Testing
- Drugs-Of-Abuse Testing
- Cardiometabolic Testing
- Oncology Testing
- Cardiology Testing
- Glucose Monitoring
- Infections Disease Testing
Test Type
- Viral Sequencing
- Serological Testing
- Determining Confirmation
Approach
- Molecular Diagnostic
- In-Vitro Diagnostic
Specimen
- Others
- Sputum
- Saliva
- Urine
- Blood
- Swab
Age Group
- Pediatric
- Adult
Product Type
- Others
- Instruments
- Consumables and Kits
Mode
- Over-the-Counter
- Professional
Modality
- Non-Laboratory Based Test
- Laboratory Based Test
Technology
- Others
- Substrate Technology
- Microfluidics
- Agglutination Assay
- Lateral Flow Immunochromatographic Assays
- Flow-Through Assays
- PCR-Based
Frequently Asked Questions
The Asia-Pacific Rapid Diagnostic Tests (RDT) Market is segmented based on Segmentation Distribution Channel, End User, Application, Test Type, Approach, Specimen, Age Group, Product Type, Mode, Modality, Technology.
Asia-Pacific Rapid Diagnostic Tests (RDT) Market was valued at USD 14.45(Revenue in USD Billion) in 2020.
Asia-Pacific Rapid Diagnostic Tests (RDT) Market is projected to grow at a CAGR of 14.51% during the forecast period of 2024 to 2032.
The estimated market value of the Asia-Pacific Rapid Diagnostic Tests (RDT) Market for final year is USD 30.61 (USD Billion).
Asia-Pacific Rapid Diagnostic Tests (RDT) Market Company Profiling
Frequently Asked Questions
The Asia-Pacific Rapid Diagnostic Tests (RDT) Market is segmented based on Segmentation Distribution Channel, End User, Application, Test Type, Approach, Specimen, Age Group, Product Type, Mode, Modality, Technology.
Asia-Pacific Rapid Diagnostic Tests (RDT) Market was valued at USD 14.45(Revenue in USD Billion) in 2020.
Asia-Pacific Rapid Diagnostic Tests (RDT) Market is projected to grow at a CAGR of 14.51% during the forecast period of 2024 to 2032.
The estimated market value of the Asia-Pacific Rapid Diagnostic Tests (RDT) Market for final year is USD 30.61 (USD Billion).
HAVE A QUESTION?
Get expert advice on the right strategy for your business at no cost. We also offer customized subscription plans and affordable discounts for startups and universities.